Clinical value of macrogenome next-generation sequencing on infections

被引:0
|
作者
Han, Benfa [1 ]
Zhang, Xiaoli [1 ]
Li, Xiuxi [1 ]
Chen, Mei [1 ]
Ma, Yanlin [2 ]
Zhang, Yunxia [1 ]
Huo, Song [1 ]
机构
[1] First Peoples Hosp HongHe State, Southern Cent Hosp Yunnan Prov, Dept Infect Dis, Honghe 661000, Yunnan, Peoples R China
[2] Southern Cent Hosp Yunnan Prov, First Peoples Hosp HongHe State, Dept Pharmaceut, Honghe 661000, Yunnan, Peoples R China
来源
OPEN LIFE SCIENCES | 2024年 / 19卷 / 01期
关键词
intracranial infection; pathogen detection; mNGS technology; clinical analysis; efficacy evaluation; DIAGNOSIS; DNA;
D O I
10.1515/biol-2022-0938
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Intracranial infection (ICI) is a frequent and serious complication after neurosurgery. Macrogenome next-generation sequencing (mNGS) technology can provide reference for clinical diagnosis and treatment of ICI. This work aimed to explore the application value of mNGS technology in analyzing the clinical characteristics of human immunodeficiency virus (HIV) infection and ICI after neurosurgery. A total of 60 patients with ICI were enrolled as the research objects, all patients underwent routine cerebrospinal fluid analysis and traditional pathogen detection, followed by mNGS genome analysis. Using clinical diagnosis of ICI as the gold standard, the sensitivity, specificity, positive predictive value, and negative predictive value for both detection methods were calculated. Receiver operating characteristic curves were constructed to assess the area under the curve (AUC) for evaluating the clinical value of mNGS in suspected intracranial infectious pathogen diagnosis. Results showed a positivity rate of 71.67% (43 cases) with mNGS compared to 28.33% (17 cases) with traditional pathogen detection methods, demonstrating a significant difference (P < 0.05). The sensitivity of mNGS for detecting ICIs was 83.7%, significantly higher than the 34.88% observed with traditional methods (P < 0.05). The pathogen detection rate of mNGS was higher than traditional methods (P = 0.002), with an AUC of 0.856 (95% CI: 0.638-0.967), significantly greater than the AUC of 0.572 (95% CI: 0.350-0.792) for traditional methods (P < 0.05). mNGS successfully identified microorganisms such as Cryptococcus, Propionibacterium, Staphylococcus, Corynebacterium, Micrococcus, and Candida associated with ICIs. These findings underscore the clinical applicability of mNGS technology in analyzing the characteristics of HIV infection and ICI post-neurosurgical procedures. This technology enables more accurate diagnosis and treatment of ICIs, providing valuable insights for developing effective therapeutic strategies. Graphical abstract
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Clinical applicability of next-generation sequencing in clinical exome
    Hrabikova, Michala
    Chvojka, Stepan
    Cerna, Leona
    Kral, Jan
    Zembol, Filip
    Honysova, Barbora
    Bittoova, Martina
    Koudova, Monika
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 936 - 936
  • [22] Clinical Value of Larger Multi-Gene Next-Generation Sequencing Panels
    Broaddus, Russell R.
    Litzenburger, Beate
    Shaw, Kenna
    Lee, Jack
    Zhang, Jiexin
    Kopetz, Scott
    LABORATORY INVESTIGATION, 2017, 97 : 454A - 454A
  • [23] Clinical diagnostic value of targeted next-generation sequencing for infectious diseases (Review)
    Chen, Qiuyue
    Yi, Jie
    Liu, Yiwei
    Yang, Chenglin
    Sun, Yujie
    Du, Juan
    Liu, Yi
    Gu, Dejian
    Liu, Hao
    Xu, Yingchun
    Chen, Yu
    MOLECULAR MEDICINE REPORTS, 2024, 30 (03)
  • [24] The Value of Next-Generation Sequencing in the Screening and Evaluation of Hematologic Neoplasms in Clinical Practice
    Northrup, Victoria
    Maybank, Allison
    Carson, Nancy
    Rahmeh, Tarek
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 153 (05) : 639 - 645
  • [25] GENETIC PROFILE IN ACUTE MYELOID LEUKEMIA: THE CLINICAL VALUE OF NEXT-GENERATION SEQUENCING
    Pereira, Coelho Daniela
    Marques, Barbara
    Roque, Adriana
    Afonso, Carolina
    Simoes, Ana Teresa
    Coucelo, Margarida
    Guilherme, Raquel
    Marini, Sandra
    Cortesao, Emilia
    Espadana, Ana Isabel
    Ribeiro, Leticia
    HAEMATOLOGICA, 2020, 105 : 205 - 205
  • [26] Clinical Value of Larger Multi-Gene Next-Generation Sequencing Panels
    Broaddus, Russell R.
    Litzenburgen, Beate
    Shaw, Kenna
    Lee, Jack
    Zhang, Jiexin
    Kopetz, Scott
    MODERN PATHOLOGY, 2017, 30 : 454A - 454A
  • [27] Next-generation sequencing and its clinical application
    Dahui Qin
    Cancer Biology & Medicine, 2019, (01) : 4 - 10
  • [28] Next-generation sequencing entering the clinical arena
    Haas, Jan
    Katus, Hugo A.
    Meder, Benjamin
    MOLECULAR AND CELLULAR PROBES, 2011, 25 (5-6) : 206 - 211
  • [29] Next-generation sequencing and clinical histocompatibility testing
    Cornaby, Caleb
    Schmitz, John L.
    Weimer, Eric T.
    HUMAN IMMUNOLOGY, 2021, 82 (11) : 829 - 837
  • [30] Next-Generation Sequencing Boosts Clinical Metagenomics
    Tay A.
    Genetic Engineering and Biotechnology News, 2022, 42 (03): : 30 - 33